Aravis

Aravis SA is a Swiss private equity firm focusing on growth investments in Switzerland and Europe. The firm targets companies in energy, life sciences, and related industries, providing capital to accelerate expansion. Aravis Growth I, their newest fund, addresses the high demand for growth capital in these regions.

With years of investment experience, Aravis has established itself as a recognized player in Swiss and European private equity markets. The firm offers active support to entrepreneurs beyond funding. Notable portfolio companies include Bellerophon Therapeutics, Bird Rock Bio, and Omeros. Aravis typically invests in Series A and B rounds, demonstrating their commitment to early-stage growth companies.